Cargando…
In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells
The capacity of T lymphocytes exposed in vitro to the neuropeptide vasoactive intestinal peptide (VIP) to bind VIP in vitro and to migrate to different tissues in vivo has been studied. VIP treatment of T cells resulted in a time- and dose-dependent loss of the ability of T cells to specifically bin...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187477/ https://www.ncbi.nlm.nih.gov/pubmed/6090573 |
Ejemplares similares
-
Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016) -
Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility
por: Nassif, A., et al.
Publicado: (1995) -
Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012) -
Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022) -
Aged human skin accumulates mast cells with altered functionality that localize to macrophages and vasoactive intestinal peptide‐positive nerve fibres
por: Pilkington, S.M., et al.
Publicado: (2018)